Showing results (601-610 of 623) with videos related to
Sort By:
Pageof 63
Emerging Microbes & Infections|February 20, 2024
Effectiveness of a broad-spectrum bivalent mRNA vaccine against SARS-CoV-2 variants in preclinical studiesJing Lu, Shudan Tan, Hao Gu, et al.Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|August 30, 2013
[Trastuzumab in combination with chemotherapy versus chemotherapy alone for first-line treatment of HER2-positive advanced gastric or gastroesophageal junction cancer: a Phase III, multi-center, randomized controlled trial, Chinese subreport]Lin Shen, Jian-ming Xu, Feng-yi Feng, et al.Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|September 2, 2008
[Phase III clinical study of zoledronic acid in the treatment of pain induced by bone metastasis from solid tumor or multiple myeloma]Mei Dong, Feng-Yi Feng, Yang Zhang, et al.Acta Pharmacologica Sinica|September 10, 2025
GluN2A-NMDA receptor inhibition disinhibits the prefrontal cortex, reduces forced swim immobility, and impairs sensorimotor gatingYuan-Ping Dong, Yun Wu, Yi-Lu Zhao, et al.International Journal of Antimicrobial Agents|March 20, 2013
Carbapenem susceptibilities and non-susceptibility concordance to different carbapenems amongst clinically important Gram-negative bacteria isolated from intensive care units in Taiwan: results from the Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2009Shio-Shin Jean, Po-Ren Hsueh, Wen-Sen Lee, et al.BMC Microbiology|June 16, 2026
2''-O-galloylhyperin as a novel adjuvant to reduce imipenem resistance in multidrug-resistant Pseudomonas aeruginosa: transcriptome-based mechanism of iron homeostasis disruptionLin Zheng, Ge-Jin Lu, Zi-Xian Wang, et al.World Journal of Gastroenterology|September 3, 2025
MicroRNA-126-3p as a predictive biomarker for patients with primary biliary cholangitis refractory to ursodeoxycholic acidShi-Da Pan, Chu-Yue Xiong, Ying-Juan Shen, et al.Journal of Medicinal Chemistry|January 23, 2025
Design of (R)-3-(5-Thienyl)carboxamido-2-aminopropanoic Acid Derivatives as Novel NMDA Receptor Glycine Site Agonists: Variation in Molecular Geometry to Improve Potency and Augment GluN2 Subunit-Specific ActivityFabao Zhao, Unai Atxabal, Sofia Mariottini, et al.Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|February 10, 2015
Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)Shio-Shin Jean, Wen-Sen Lee, Kwok-Woon Yu, et al.Clinical Oral Investigations|August 24, 2023
Tooth ultrastructure changes induced by a nonsense mutation in the FAM83H gene: insights into the diversity of amelogenesis imperfectaLi Tan, Yue Guo, Meng-Mei Zhong, et al.Pageof 63